Pearl Health’s AI Cracks the Code to Profitable, Proactive Medicare

NEW YORK, NY – July 08, 2026 – In a health-tech landscape littered with ambitious promises and steep cash burn, Pearl Health has emerged as a rare signal of sustainable success. The healthcare technology company announced today a $110 million capital raise to scale its AI platform, which helps doctors succeed in value-based care models for Medicare patients. But the real headline isn't the funding—it's the proof point behind it. Pearl Health reached profitability in 2025, a milestone few of its growth-stage peers have achieved.

This financial validation, coupled with projections to generate half a billion dollars in gross healthcare savings by the end of 2026, signals a pivotal shift. It suggests that the long-sought transition from a reactive, fee-for-service healthcare system to a proactive, outcomes-based model may have finally found its technological and economic engine. The new financing, comprised of a $50 million equity round led by Andreessen Horowitz (a16z) and a $60 million debt facility from Trinity Capital, will fuel the company’s expansion into new markets, including the fiercely competitive Medicare Advantage space.

"Pearl was founded on a simple belief: healthcare should reward keeping people healthy, not just treating them when they are sick," said Michael Kopko, co-founder and CEO of Pearl Health. "Unnecessary costs and poor outcomes persist in US healthcare because most providers lack the capabilities to shift to outcomes-based care alone. With this financing, we are investing in accelerated innovation and growth to expand our impact across the healthcare system."

The Profitability Paradox in Health AI

For investors and healthcare executives, Pearl Health’s trajectory presents a compelling case study. The company has managed to align improved patient outcomes with a sustainable business model, a dual success that has proven elusive for many. While the broader health AI market is projected to unlock hundreds of billions in annual savings, many solutions have operated as cost centers, requiring heavy investment in both technology and clinical staff to function.

Pearl’s model breaks from this tradition. By focusing on technology as a force multiplier, the company enables providers to manage risk across large patient populations without a proportional expansion of their clinical workforce. This is the crux of their value proposition and a key driver of investor confidence.

"Pearl has demonstrated that managing risk across large patient populations across many different settings of care can improve patient outcomes, generate meaningful savings, and support a sustainable business model at scale," noted Vineeta Agarwala, MD, a general partner at Andreessen Horowitz. "Pearl's ability to enable providers to participate in value-based payment programs successfully – and to do so through technology, rather than clinical workforce expansion – is a testament to both the vision and execution of the Pearl team."

This tech-first approach is what allows the company to manage approximately $3.6 billion in annualized medical spend for its network of over 10,000 providers. The platform’s efficiency is designed to reduce the operational labor costs associated with value-based care by as much as 40% compared to traditional methods, a critical factor for physician practices operating on thin margins.

From Reactive Treatment to Predictive Intervention

At the heart of Pearl Health’s success is its AI platform, a sophisticated engine designed to sift through mountains of clinical and claims data to find the signals that matter. It replaces slow, retrospective reports with real-time insights, giving care teams a dynamic view of their patient population. The platform’s “Performance Intelligence” layer uses predictive analytics to identify patients on a trajectory toward higher risk, allowing providers to intervene before a chronic condition escalates into a costly emergency room visit or hospital admission.

This isn't just about flagging high-risk patients; it's about orchestrating the entire workflow. The platform’s “Care Orchestration AI agents” automate burdensome administrative tasks that plague modern medicine—from scheduling annual wellness visits and post-discharge follow-ups to managing outreach campaigns. By handling these routine but critical functions, the AI frees clinicians to practice at the top of their license, focusing their time and expertise on direct patient care.

Provider networks that have adopted the technology report a tangible shift in their daily operations. The CEO of one partner, a large provider network in Hawaii, recently noted that Pearl’s predictive technology empowers their primary care physicians to proactively focus on patients who need the most attention, leading to demonstrably better care at a lower cost. Another medical director at a North Carolina-based practice found the model enabled more effective use of his care teams, crediting the platform with reducing routine tasks and freeing up valuable provider time.

"We believe Pearl Health is changing how providers participate in value-based care, simplifying the data and daily workflow so they can spend more of their time and attention on their patients," said Phil Gager, Senior Managing Director at Trinity Capital.

Navigating the $1 Trillion Medicare Challenge

Pearl’s growth is set against the backdrop of a monumental challenge: the soaring cost of Medicare, which now exceeds $1 trillion annually for over 70 million Americans. In response, the Centers for Medicare & Medicaid Services (CMS) has aggressively pushed a transition toward value-based care models like Accountable Care Organizations (ACOs), where providers are financially rewarded for quality outcomes and cost savings.

However, succeeding in these risk-bearing arrangements is complex. It requires a level of data analytics, population health management, and financial modeling that most independent practices and even some health systems lack. This is the gap Pearl Health fills. The company acts as a tech-enabled partner, providing the infrastructure and intelligence necessary for providers to confidently take on financial risk and share in the resulting savings.

Since its founding in 2020, the company has rapidly expanded its footprint to over 40 states, supporting major health systems like the University of Vermont Health Network alongside independent physician groups. The rapid growth in medical spend under its management—from $1.6 billion two years ago to $3.6 billion today—underscores the accelerating demand for its platform as more providers move away from the fee-for-service treadmill.

The Next Frontier: Medicare Advantage and Expanding Risk

The new infusion of $110 million is not just for scaling the current model; it’s for conquering new territory. A primary focus will be expanding into the Medicare Advantage (MA) market, a segment that now covers more than half of all Medicare beneficiaries. The MA landscape is dominated by large insurance carriers and is notoriously competitive, but it represents a massive opportunity for a company that has honed its ability to manage risk and drive savings.

By offering its platform to MA plans and their provider networks, Pearl Health can extend its impact to a larger patient population while diversifying its business. The capital will also fund the development of new risk offerings, allowing the company to support providers across a full spectrum of value-based arrangements, from introductory shared-savings models to full-risk accountability.

This strategic expansion positions Pearl Health not just as a vendor for a specific government program, but as a foundational platform for the future of healthcare outcomes. As the industry continues its inexorable march toward paying for value, the ability to intelligently manage risk with technology is no longer a competitive advantage—it is a condition for survival.